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Abstract
Background: To find out the prevalence, clinical and biochemical correlates of Breast Artery Calcification (BAC) in
the Nigerian women.
Findings: This is a cross sectional study involving 54 consecutive adult female subjects sent to the Radiology
Department of the Lagos State University Teaching Hospital (LASUTH), Ikeja-Lagos, Nigeria for screening and
diagnostic mammography. The study was carried out for a period of five months.
The prevalence of BAC was 20%. Ageing was found to be related to BAC. Cardiovascular risk factors including
diabetes mellitus (DM), hypertension, obesity, alcohol ingestion, use of oral contraceptives and hormone
replacement therapy, were not significantly related to the presence of BAC in this study.
Conclusion: This study showed that though the presence of BAC in a mammogram is related to age, it may not
predict or serve as a significant marker for cardiovascular diseases (CVD) in women in our environment.
Background
Arterial calcification is a common feature of athero-
sclerosis which can be elicited with conventional radi-
ological imaging as calcium deposits in the arterial wall
[1]. The appearance of calcium in different vascular
beds occurs 10-15 years later in women than in men
[1]. Breast Artery Calcification (BAC) on mammography
was seen in 9% of women in a study that was carried
out in Utrecht, The Netherlands. BAC has been identi-
fied as calcific medial sclerosis of medium sized breast
arteries and was reported to be associated with cardio-
vascular risk factors including diabetes mellitus [DM],
hypertension [2], coronary artery disease (CAD) and car-
diovascular mortality [1,3-6].
Histopathologically, medial calcification differs from
intimal calcification in the absence of signs of inflamma-
tion and lipid deposits [1,7]. Conventional x-ray techni-
ques cannot however differentiate between intimal and
medial calcification. Medial calcification is finer and dif-
fuse in smaller vessels, while intimal thickening in large
and medium sized arteries, are large and discontinuous
[1,3,7]. Atherosclerosis and medial sclerosis appear more
frequently and at an earlier age in diabetic patients [8].
Fiuza et al [9] suggested that mammographic finding of
BAC calls for more attention from the Radiologist and
should not be excluded from reports.
Vascular calcifications in the breast are defined as the
presence of parallel linear calcified deposits along the
course of a vessel that is seen on at least one view of a
mammogram [7,10]. They are called Monckeberg calcifi-
cations and involve the middle layer of arteries [3,7,10].
They are diffuse, thin and involve the whole circumfer-
ence of the peripheral arteries making the vessels stiff.
These are uncommon in patients less than 50 years old
and are found in about 9.1% mammograms [2,3,7,10,11].
The prevalence of vascular calcification ranges from 9-
17% and increases with age, exceeding 50% in women
aged 65 years and above [10,12]. Other studies have
found associations between BAC and chronic diseases
including kidney failure, autonomic neuropathy and
hypervitaminosis D [10] and also with Cardiovascular
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any medium, provided the original work is properly cited.risk factors which include increasing age, parity, obesity,
cigarette smoking, alcohol ingestion, use of oral contra-
ceptives or hormone replacement therapy, diabetes,
hypertension and deranged lipid profile [2].
BAC that is seen in breast cancer screening mammo-
grams may also be associated with disorders related to
increased or accelerated atherosclerosis [13]. Increased
parity has been associated with decrease in breast cancer
risk but increases the occurrence of BAC [13]. Breast can-
cer screening may also aid early detection of enhanced
CVD risk among otherwise healthy women [13].
This study is aimed at finding the prevalence of BAC
and its relationship with cardiovascular (CVD) risk fac-
tors in Lagos, Nigeria.
Methods
Fifty-four consecutive adult female subjects that were
sent for screening and diagnostic mammography
between February and June 2010 were recruited for this
prospective study. All the subjects consented to the
study. Interviewer administered questionnaire which
included information on the biodata and anthropometric
measurements comprising of waist circumference, height
and body weight were answered by the patients. The
Body Mass Index (BMI) was calculated using the for-
mula- weight/height
2 (kg/m
2) for the patients [10]. The
waist circumference was measured at the midpoint
between the inferior margin of the 10th rib and the
crest of the ilium with a tape measure. The medical his-
tory of any previous stroke and or heart failure and
necessary information on the risk factors for CVD were
also obtained.
The mammograms, cephalocaudal (CC) and mediolat-
eral oblique (MLO) views were done using a Villa Sys-
temi Stereotactic Mammography machine and these
were assessed for BAC using a well illuminated viewing
box and hand lens.
An excel data spreadsheet was used to record all these
information. Statistical Package for Social Sciences
(SPSS), version 17, Chicago Illinois was used for statisti-
cal analysis
Statistical Analyses
Descriptive results for continuous variables were
expressed as mean ± standard deviation (SD). Biochem-
ical and clinical parameters were compared between the
study subjects with and without BAC using independent
samples t-test for continuous variables and chi-square
for categorical data. Possible predictors for the presence
of BAC were evaluated using binary logistic regression.
The variables entered in the model included CVA risk
factors (obesity, central obesity, elevated LDL, elevated
total cholesterol and dyslipidaemia). A p-value < 0.05
was considered statistically significant.
Biochemical analyses
Lipid parameters
Fasting venous blood samples were taken for the deter-
mination of High Density Lipoprotein-Cholesterol
(HDL-C), and Triglyceride (TG). HDL-C was deter-
mined by the precipitation method [14] and TG esti-
mated using a standardized kit employing enzymatic
hydrolysis of TG with lipases [15]. Fasting Blood Sugar
(FBS) level estimation was done as a point of care test
using a glucometer (Glucolab manufactured by Infopia
Limited, Korea Republic) from fasting capillary blood
samples. Total cholesterol (TCHOL), Low density Lipo-
protein Cholesterol (LDL-C), Very Low Density Lipo-
protein (VLDL) and electrolyte and urea (E&U) were
also assessed. The serum levels of Total protein and
albumin were also checked.
Operational definitions
1. Abnormal lipid parameters refers to elevated TCHOL,
LDL, TG and reduced HDL [16].
2. Dyslipidaemia refers to serum triglycerides (TG)
level of at least 150 mg/dl, high-density lipoprotein cho-
lesterol (HDL-C) level of less than 50 mg/dl [17].
3. Hypercholesterolaemia and elevated LDL refers to
TCHOL > 200 mg% and LDL-C > 100 mg% [16].
4. Obesity was defined as abnormal or excessive fat
accumulation that may impair health. Obesity refers to a
BMI >to 30 [18].
5. Central obesity was when the waist circumference
(WC) dimension was greater than 88 cm [17].
6. BAC was diagnosed when easily recognized charac-
teristic pattern of two linear parallel calcific lines giving
a “railroad track” configuration described by Sickles was
seen on the mammogram [3,7,10,19], (Figure 1).
Results
This study revealed that the older the patient, the
more the possibility of developing BAC, as shown in
(Table 1). Most of the BAC seen in this study occurred
between 60 - 69 years while none was seen below 40
years, (Table 1).
Only six (11.15%) participants had a significant
history of alcohol ingestion, none of them smoked
cigarette and none had a past or present history of car-
diovascular accident (CVA) or heart failure. The
potential risk factors for BAC in the study subjects are
s h o w ni n( T a b l e2 ) .
About one fifth of the study subjects had BAC, with a
prevalence of 20% and of all the correlates, only the
difference in the ages of subjects with and without BAC
was statistically significant( p=0 . 0 0 2 ) , ( T a b l e3 ) .T h o s e
that had BAC were obese with an average BMI of 31.3
Kg/m
2 though not statistically significantly different
f r o mt h o s et h a td i dn o th a v eB A C .T h e i rf a s t i n gb l o o d
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and biochemical correlates were not statistically signifi-
cant, (Table 3).
Table 3 also shows that although the mean age of the
subjects with BAC was significantly higher than the sub-
jects without BAC, all other mean values of their clinical
and biochemical parameters were comparable.
The distribution of CVD risk factors were similar in
subjects with and without BAC and Figure 2 shows that
apart from the elevated total cholesterol, the proportion
of subjects with BAC who had the CVD risk factors
depicted in the figure was less than 50%.
Of the 34 subjects who were menopausal, only 3
(8.8%) were found to have vascular calcifications, and
the difference in the occurrence of BAC in subjects with
or without history of the use of oral contraceptives was
not statistically significant (p = 0.09). Only One subject
among those with history of the use of HRT had vascu-
lar calcification and there was no statistically significant
difference in the occurrence of vascular calcifications
among the subjects with and without history of usage of
HRT (p = 0.7). Vascular calcification was not found in
any of the participants with a history of alcohol inges-
tion or DM, while all except 2 (18,2%) of the subjects
with BAC breast fed. This study has therefore shown
that none of the possible predictors of BAC that were
investigated was statistically significant, (Table 4).
Sites of BAC
BAC was found in 5(45.5%) breasts on the right and 2
(18.2%) on the left. It occurred bilaterally in 4(36.4%).
Two (18.2%) of those that had BAC were nulliparous.
All the quadrants of the breasts were equally affected
(upper, 36.4%, lower, 36.4% and upper and lower,
27.2%).
Discussion
The significance of BAC on mammograms is still deba-
table. While some authors claim that it might be a use-
ful means of predicting CVD in women, others are of
contrary opinion [1,8,12,19].
       
Figure 1 Showing the CC and MLO views of a mammogram with “Tram-like calcifications” in the upper quadrant of the breast in an
80 year old woman who incidentally also had a malignant breast mass.
Table 1 Distribution of BAC according to age decades in
the study subjects
Age Range
(years)
Subject
Fequency (%)
BAC
Frequency
(%)
BAC Frequency/Subject
frequency (%)
30 - 39 1 (1.9) 0 (0) 0%
40 - 49
years
20 (37.0) 2 (18.2) 10%
50 - 59
years
21 (38.9) 2 (18.2) 9.5%
60 - 69
years
10 (18.5) 5 (45.5) 50%
> 70 years 2 (3.8) 2 (18.2) 100%
Table 2 Distribution of some risk/potential factors for
BAC
Parameter No. (Frequency)%
Breast Feeding 48 (89%)
Hypertension 19 (35%)
DM 5 (9%)
History of usage of oral contraceptive 10 (18%)
History of use of hormone replacement therapy 4 (8%)
Alcohol ingestion 6 (11,1%)
Menopausal status 34 (62%)
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associated with BAC. Women with BAC were signifi-
cantly older than those without BAC in the present
study. Maas et al [1] noted in their study that BAC was
associated with increasing age, pregnancy and lactation
but not with the traditional CVD risk factors. Kim et al
[7] claim that Sickle and Galvin and Taskin et al [20]
also found that at mammography, visible BAC are posi-
tively correlated with increased age. BACs were seen
more frequently in postmenopausal women in other
studies [7], while a study in Brazil by Ferreira et al [21]
found that significantly more women with BAC had
CVD compared to women who did not have BAC. This
is however contrary to the finding in this study where
only 3 (8.8%) of the postmenopausal women had BAC.
Parity and breast feeding did not show any significant
relationship with BAC in the present study. Previous
studies have not been conclusive as to whether preg-
nancy and lactation may have any role in the calcifica-
tion of other vascular beds besides breast arteries [1].
Vascular calcifications in the breast usually have a lipid
component and resemble calcifications seen in other
arteries [10]. The mechanism of deposition is still
unknown. Oliveira et al [10] claim that when present,
BAC was always bilateral. This may be a reflection of the
atherosclerotic process and consequent vascular
calcification affecting the whole arterial system. This was
not true in this study as only 36.4% had bilateral BAC.
Although BAC was reported by Baum et al [8] as a
sign of coexisting diabetes, none of the diabetics in this
study had BAC. Findings in this study were also con-
trary to the study by Moshyedi et al [19], who reported
that nearly all women in their study group younger than
59 years with BAC also had CAD and DM [7,11].
Studies have listed age, hypertension, hypercholester-
aemia, DM and menopause as the risk factors for CVD
Table 3 Comparison of clinical and biochemical variables
between the subjects with and without BAC
Variables Subjects with BAC Subjects without BAC p value
Age (years) 60 (10.1) 50.9 (7.8) 0.002
BMI (Kg/m
2) 31.3 (4.9) 28 (4.9) 0.09
WC (cm) 93.5 (10.6) 93.4 (17.5) 0.9
Weight (Kg) 78.9 (11) 73.7 (13.5) 0.2
T chol (mg%) 177.4 (32.9) 178.4 (36.9) 0.1
TG (mg%) 79 (28.2) 65.7 (22.5) 0.3
HDL-C (mg%) 50 (9) 45.7 (14.3) 0.6
LDL-C (mg%) 126 (37.9) 120.6 (32) 0.9
Total protein 7.1 (0.3) 7.1 (0.6) 0.9
FBS 85 (13.9) 86.1 (15) 0.8
Albumin 3.5 (0.3) 3.7 (0.6) 0.08
*Results are expressed as means and standard deviations
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Figure 2 Distribution of cardiovascular risk factors in the study subjects and in those with vascular calcifications. Series 1: Proportion of
study subjects with CVD abnormalities Series 2: Proportion of the subjects with stated CVD abnormalities that had mammary vascular
calcification.
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cant factor that was found in the present study. This is
similar to the findings by Kataoka et al [12].
The prevalence of BAC in this study is much higher
than those of previous studies which were mostly done
among the Caucasians [10,12,13,22]. The reason for the
high prevalence in our environment is not known. Fac-
tors that may arise from racial differences between the
subjects of this study (who are mostly black Africans)
and those of other studies may be responsible. However,
not much work has been done in this regard in Nigeria
or Africa.
A study by Maas et al [1] has suggested a strong asso-
ciation between pregnancy, breast feeding and BAC.
Pregnancy is associated with major changes in calcium
metabolism to meet the high requirements for fetal
growth and breast milk production. Pregnancy and
breastfeeding induce transient hypercalcaemia. These
may lead to calcium deposits in the breast arteries [1].
Contrary to the findings by Yildiz et al [6] that signifi-
cantly linked increasing number of childbirths with
BAC, there was no significant difference between the
number of childbirths in subjects that had BAC and
those that did not have BAC in this study. Our finding
was also contrary to that of Maas et al [1].
T h eB M Iw a sa l s on o ts i g n i f i c a n t l yh i g h e ri nt h es u b -
j e c t sw i t hB A C .T h i si sc o n t r a r yt ot h er e s u l t sf r o m
other studies [1-3]. We cannot explain the reason for
this difference.
This study did not show any relationship between
BAC and chronic diseases such as hypertension, and
diabetes. This is in contrast with findings from studies
by Kemmerem et al [2] and Oliveira et al [10].
Conclusion
We report the prevalence rate of BAC to be 20% in our
environment. Increasing age was the only factor which
we found to be related to its presence. All the other
CVD risk factors that were found in previous literatures
were not associated with the presence of BAC in this
study. Therefore, BAC found in screening and diagnos-
tic mammography may not be a marker for CVD in
w o m e ni no u re n v i r o n m e n t .T ot h eb e s to fo u rk n o w l -
edge, not much work has been done in Nigeria and
Africa on this. It is recommended that further studies
should be done to elicit the reasons for the high preva-
lence and the differences in the risk factors among
Nigerians.
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